Inflammatory bowel disease TLR5 may play a role in
inflammatory bowel disease (IBD), since TLR5 expression on intestinal epithelial cells (IEC's) are important for maintaining the composition of intestinal microbiota. Additionally, TLR5-deficient mice develop spontaneous colitis and metabolic syndrome which are associated with altered gut microbiota. Statistically significant lower levels of TLR5 expression have been found in patients exhibiting moderate to severe
ulcerative colitis (UC). In these patients, lower TLR5 mRNA levels were found along with decreased immunoreactivity of TLR5 in the inflamed mucosa of UC patients.
Osteoclastogenesis and bone loss Bone loss and osteoclastogenesis are induced by inflammation in infectious and autoimmune diseases. A recent study has identified TLR5 as a novel mediator in the process of inflammation-induced bone loss and osteoclastogenesis.
Flagellin, which is a TLR5-activating ligand, is present in
synovial fluid from patients with
rheumatoid arthritis. Activation of TLR5 in these patients leads to subsequent activation of
receptor activator of NF-κB ligand (RANKL). Activation of RANKL leads to increased expression of osteoclastic genes. Activation of these genes results in robust
osteoclast formation and bone loss. TLR5 is an essential factor in inducing inflammatory response to
H. pylori infection. During infection, expression and ligation of TLR5 and
TLR2 are required for the activation of proinflammatory cytokines such as
NF-κB. However, TLR5 interaction with
H. pylori only induces weak TLR5 activation. The inflammatory response induced by TLR5 during
H. pylori is also considered to be possibly
flagellin independent. This suggests that an unknown
H. pylori factor is responsible for this response This is supported by the increased level of TLR5 expression from normal gastric
mucosa to gastric cancer cells.
Cervical TLR5 is suggested to be possibly involved in
HPV induced inflammation and subsequent cervical neoplasia formation. However, the exact mechanism of interaction between TLR5 and HPV is not known.
Ovarian It has been reported that TLR5 expression is detected in both ovarian epithelium and
ovarian cancer cell lines but not in ovarian stroma, suggesting a possible role of TLR5 in inflammation induced ovarian cancer onset. == References ==